Stomach Cancer Medications

FLUOROURACIL treats some types of cancer. It works by slowing down the growth of cancer cells.

DOXORUBICIN treats some types of cancer. It works by slowing down the growth of cancer cells.

MITOMYCIN treats stomach cancer and pancreatic cancer. It works by slowing down the growth of cancer cells.

Taxotere (docetaxel) is used to treat breast cancer, lung cancer, prostate cancer, skin cancer, and stomach cancer. Taxotere is a Microtubule Inhibitor, which works by stopping cancer cell growth and preventing the spread of the cells. The most common form of Taxotere is a 20mg/ml vial. It's also available in a 80mg/4ml vial. Taxotere is available as generic docetaxel. It is covered by some Medicare and insurance plans.

Docivyx is part of the Microtubule Inhibitors class and treats Lung Cancer, Skin Cancer, Stomach Cancer and other conditions. Microtubule inhibitors are used to treat ovarian cancer, breast cancer, lung cancer, kaposi's sarcoma, and prostate cancer. They work by stopping cancer cell growth and preventing the spread of the cells. Docivyx is only available as a brand name drug.

Hercessi is part of the HER2 Receptor Antagonists class and treats Stomach Cancer and Breast Cancer. HER2 receptor antagonists are used to treat breast cancer. They work by targeting cancer cells that express HER2. Hercessi is only available as a brand name drug.

Ogivri (trastuzumab-dkst) is used to treat stomach and breast cancer. Ogivri is a HER2 Receptor Antagonist, which works by targeting cancer cells that express HER2. The most common form of Ogivri is a 150mg vial. It is also available as a 420mg vial. Ogivri is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. It may be covered by some Medicare and insurance plans.

Herzuma (trastuzumab-pkrb) is used to treat stomach and breast cancer. Herzuma is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Herzuma may be covered by your Medicare or insurance plan.

Ontruzant (trastuzumab-dttb) is used to treat stomach and breast cancer. Ontruzant is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Ontruzant may be covered by your Medicare or insurance plan.

Kanjinti (trastuzumab-anns) is used to treat stomach and breast cancer. Kanjinti is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Kanjinti may be covered by your Medicare or insurance plan.

Trazimera (trastuzumab-qyyp) is used to treat stomach and breast cancer. Trazimera is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Trazimera may be covered by your Medicare or insurance plan.

Opdivo Qvantig is part of the Monoclonal Antibodies class and treats Esophageal Cancer, Lung Cancer, Skin Cancer and other conditions. Monoclonal antibodies are used to treat many conditions, including cancers, autoimmune diseases, and certain infections. They are similar to the antibodies in the body's immune system. But they are lab-made to have a specific target based on the condition they treat. Targets can include cancer cells, viruses, immune cells, and certain receptors in the body. Opdivo Qvantig is only available as a brand name drug.

Beizray is part of the Microtubule Inhibitors class and treats Lung Cancer, Skin Cancer, Stomach Cancer and other conditions. Microtubule inhibitors are used to treat ovarian cancer, breast cancer, lung cancer, kaposi's sarcoma, and prostate cancer. They work by stopping cancer cell growth and preventing the spread of the cells. Beizray is only available as a brand name drug.

RAMUCIRUMAB treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. It is a monoclonal antibody.

Herceptin (trastuzumab) is used to treat stomach and breast cancer. Herceptin is also available as a biosimilar. Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Herceptin may be covered by your Medicare or insurance plan.

PEMBROLIZUMAB treats some types of cancer. It works by helping your immune system slow or stop the spread of cancer cells. It is a monoclonal antibody.

Rozlytrek (entrectinib) is used to treat adrenal cancer, breast cancer, cervical cancer, colon cancer, liver cancer, lung cancer, ovarian cancer, pancrearic cancer, prostate cancer, renal cancer, skin cancer, stomach cancer, testicular cancer, thryoid cancer and uterine cancer. Rozlytrek is a Kinase Inhibitor, which works by preventing cancer cell growth. The most common form of Rozlytrek is a 100mg capsule. It is also available as a 200mg capsule and a cartson of 50, 42mg packets. There are currently no generic alternaitves for Rozlytrek. It may be covered by some Medicare and insurance plans.

LAROTRECTINIB treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.